Experts back biomarker test to catch HGH users

The Associated Press reported this week that a new biomarker test that could spot evidence of human-growth hormone in the blood for up to 21 days has garnered support from experts and scientists ahead the Olympics in London next year. The new test detects chemicals that the body produces after HGH use that stay in the system much longer the performance-enhancer itself, according to the report. "The consensus is that this test is a well-validated, scientifically reliable test which extends the window of detection and would also be important to implement," U.S. Anti-Doping Agency CEO Travis Tygart told the AP. Report

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.